Patents by Inventor Anita SCHEUBER

Anita SCHEUBER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CD47 BLOCKING AGENT AND ANTI-CD20 / ANTI-CD3 BISPECIFIC ANTIBODY COMBINATION THERAPY
    Publication number: 20260201052
    Abstract: Dosing regimens and methods for administering combination therapies combining a CD47 blocking agent and an anti-CD20/anti-CD3 bispecific antibody are provided. The dosing regimens and methods may further include additional therapeutic agents.
    Type: Application
    Filed: December 8, 2023
    Publication date: July 16, 2026
    Applicants: Pfizer Inc., Hoffmann-La Roche Inc.
    Inventors: Ingmar Bruns, Victor Ruberio Lincha, Linda Maria Lundberg, James Christopher Relf, Anita Scheuber, Diane Dan Wang, Yibo Wang
  • COMBINATION THERAPY COMPRISING SIRP ALPHA FUSION PROTEIN AND ANTI-CD19 ANTIBODY FOR TREATMENT OF CANCER
    Publication number: 20260166112
    Abstract: Combination therapies comprising a SIRPaFc fusion protein and an anti-CD19 agent are provided. The combination therapies can optionally further include an E3 ubiquitin ligase modulator.
    Type: Application
    Filed: June 9, 2023
    Publication date: June 18, 2026
    Inventors: Ingmar BRUNS, Victor Ruberio LINCHA, Sandra Jean MEECH, Anita SCHEUBER, Diane Dan WANG, Yibo WANG
  • Dosing Regimens of SIRP Alpha Fusion Proteins for Treatment of Cancer
    Publication number: 20250345395
    Abstract: Dosing regimens and methods for administering SIRPaFc fusion proteins are provided. The dosing regimens and methods include both SIRPaFc monotherapies and combination therapies.
    Type: Application
    Filed: May 22, 2023
    Publication date: November 13, 2025
    Applicant: PFIZER INC.
    Inventors: Margaret Victoria Elizabeth ALLGOOD, Ingmar BRUNS, Victor Ruberio LINCHA, Dmitri PAVLOV, Anita SCHEUBER, Diane Dan WANG, Yibo WANG